GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEF) » Definitions » Shiller PE Ratio

Ipsen (IPSEF) Shiller PE Ratio : 24.10 (As of May. 06, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Ipsen Shiller PE Ratio?

As of today (2024-05-06), Ipsen's current share price is $117.60. Ipsen's E10 for the fiscal year that ended in Dec23 was $4.88. Ipsen's Shiller PE Ratio for today is 24.10.

The historical rank and industry rank for Ipsen's Shiller PE Ratio or its related term are showing as below:

IPSEF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 21.01   Med: 37.53   Max: 89.56
Current: 23.69

During the past 13 years, Ipsen's highest Shiller PE Ratio was 89.56. The lowest was 21.01. And the median was 37.53.

IPSEF's Shiller PE Ratio is ranked better than
53.11% of 531 companies
in the Drug Manufacturers industry
Industry Median: 25.32 vs IPSEF: 23.69

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ipsen's adjusted earnings per share data of for the fiscal year that ended in Dec23 was $8.430. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $4.88 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ipsen Shiller PE Ratio Historical Data

The historical data trend for Ipsen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Shiller PE Ratio Chart

Ipsen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.98 29.67 25.75 24.33 22.32

Ipsen Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.75 - 24.33 - 22.32

Competitive Comparison of Ipsen's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ipsen's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipsen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ipsen's Shiller PE Ratio falls into.



Ipsen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ipsen's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=117.60/4.88
=24.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipsen's E10 for the fiscal year that ended in Dec23 is calculated as:

For example, Ipsen's adjusted earnings per share data for the fiscal year that ended in Dec23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec23 (Change)*Current CPI (Dec23)
=8.43/118.2300*118.2300
=8.430

Current CPI (Dec23) = 118.2300.

Ipsen Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 2.306 99.860 2.730
201512 2.505 100.040 2.960
201612 2.880 100.650 3.383
201712 3.882 101.850 4.506
201812 5.324 103.470 6.083
201912 -0.678 104.980 -0.764
202012 7.993 104.960 9.004
202112 8.768 107.850 9.612
202212 8.273 114.160 8.568
202312 8.430 118.230 8.430

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ipsen  (OTCPK:IPSEF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Ipsen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Ipsen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipsen (IPSEF) Business Description

Traded in Other Exchanges
Address
65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.